These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25404436)

  • 1. Efficacy of clarithromycin in pityriasis rosea.
    Ahmed N; Iftikhar N; Bashir U; Rizvi SD; Sheikh ZI; Manzur A
    J Coll Physicians Surg Pak; 2014 Nov; 24(11):802-5. PubMed ID: 25404436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial.
    Sharma PK; Yadav TP; Gautam RK; Taneja N; Satyanarayana L
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):241-4. PubMed ID: 10642679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of azithromycin in pityriasis rosea: a randomized, double-blind, placebo-controlled trial.
    Pandhi D; Singal A; Verma P; Sharma R
    Indian J Dermatol Venereol Leprol; 2014; 80(1):36-40. PubMed ID: 24448121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral erythromycin is ineffective in the treatment of pityriasis rosea.
    Bukhari IA
    J Drugs Dermatol; 2008 Jul; 7(7):625. PubMed ID: 18664152
    [No Abstract]   [Full Text] [Related]  

  • 5. Pityriasis rosea with palmoplantar plaque lesions.
    Bukhari I
    Dermatol Online J; 2005 Mar; 11(1):27. PubMed ID: 15748568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyclovir is not effective in pityriasis rosea: Results of a randomized, triple-blind, placebo-controlled trial.
    Singh S; ; Tiwary NK
    Indian J Dermatol Venereol Leprol; 2016; 82(5):505-9. PubMed ID: 27212277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin does not cure pityriasis rosea.
    Amer A; Fischer H
    Pediatrics; 2006 May; 117(5):1702-5. PubMed ID: 16651327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral erythromycin is ineffective in the treatment of pityriasis rosea.
    Rasi A; Tajziehchi L; Savabi-Nasab S
    J Drugs Dermatol; 2008 Jan; 7(1):35-8. PubMed ID: 18246696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesicular palmoplantar pityriasis rosea.
    Singh V; Sharma M; Narang T; Madan M
    Skinmed; 2012; 10(2):116-8. PubMed ID: 22545332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of high-dose acyclovir in pityriasis rosea.
    Drago F; Vecchio F; Rebora A
    J Am Acad Dermatol; 2006 Jan; 54(1):82-5. PubMed ID: 16384760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind randomized placebo-controlled trial to evaluate the efficacy and safety of short-course low-dose oral prednisolone in pityriasis rosea.
    Sonthalia S; Kumar A; Zawar V; Priya A; Yadav P; Srivastava S; Gupta A
    J Dermatolog Treat; 2018 Sep; 29(6):617-622. PubMed ID: 29363373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Author's Response--The efficacy of azithromycin in pityriasis rosea: a randomized, double-blind, placebo-controlled trial.
    Pandhi D; Verma P; Singal A; Sharma R
    Indian J Dermatol Venereol Leprol; 2015; 81(1):57. PubMed ID: 25566901
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative study of effectiveness of oral acyclovir with oral erythromycin in the treatment of Pityriasis rosea.
    Amatya A; Rajouria EA; Karn DK
    Kathmandu Univ Med J (KUMJ); 2012; 10(37):57-61. PubMed ID: 22971864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geographic tonguelike presentation in a child with pityriasis rosea: Case report and review of oral manifestations of pityriasis rosea.
    Alzahrani NA; AlJasser MI
    Pediatr Dermatol; 2018 Mar; 35(2):e124-e127. PubMed ID: 29436009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.
    Nienhuis WA; Stienstra Y; Thompson WA; Awuah PC; Abass KM; Tuah W; Awua-Boateng NY; Ampadu EO; Siegmund V; Schouten JP; Adjei O; Bretzel G; van der Werf TS
    Lancet; 2010 Feb; 375(9715):664-72. PubMed ID: 20137805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vesicular pityriasis rosea: response to erythromycin treatment.
    Miranda SB; Lupi O; Lucas E
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):622-5. PubMed ID: 15324412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence and persistence of macrolide resistance in oropharyngeal flora and elimination of nasal carriage of Staphylococcus aureus after therapy with slow-release clarithromycin: a randomized, double-blind, placebo-controlled study.
    Berg HF; Tjhie JH; Scheffer GJ; Peeters MF; van Keulen PH; Kluytmans JA; Stobberingh EE
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4183-8. PubMed ID: 15504839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of pityriasis rosea in black American children: how correct is the "classic" description?
    Amer A; Fischer H; Li X
    Arch Pediatr Adolesc Med; 2007 May; 161(5):503-6. PubMed ID: 17485628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose of acyclovir may be an effective treatment against pityriasis rosea: a random investigator-blind clinical trial on 64 patients.
    Rassai S; Feily A; Sina N; Abtahian S
    J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):24-6. PubMed ID: 20477925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical pityriasis rosea: clinical evaluation of 27 patients.
    Kilinc F; Akbas A; Sener S; Aktaş A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):157-162. PubMed ID: 27558764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.